Plain-English translation of NCT07782164 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a treatment called irreversible electroporation (IRE) for cancers that have returned in the pelvic area — the lower part of your belly. IRE uses carefully controlled electrical pulses to destroy cancer cells. The researchers are collecting data from past patients treated with this method, as well as following new patients going forward, to understand how well and safely this treatment works.
When cancer comes back in the pelvis after initial treatment, doctors have limited options — surgery and radiation therapy may not always be possible or safe. This treatment offers a potential new way to target these recurrent tumors when traditional options are not suitable.
You likely qualify if…
You likely don't qualify if…
For patients treated before April 2025, researchers will review your existing medical records and imaging scans. For new patients joining the study going forward, you will receive the electrical pulse treatment (irreversible electroporation) as planned by your cancer care team, and researchers will collect information about your treatment and how you recover over time. The study is designed to track outcomes and safety in people whose cancer has returned in the pelvis.
AI-generated summary from trial data · Oct 4, 2026 · Not medical advice
Netherlands